# Trade Mark Journal No.2026/034 21 August 2026

## WO0000001931597 (5,42)

Office of origin: United States of America

Date of International Registration:15 July 2026
Date of designation in the UK: 15 July 2026

International priority date claimed: 20 March 2026 (United States of America) (99715372)

Class 5
  Pharmaceutical preparations for the treatment of neurodegenerative disorders.
Class 42
  Pharmaceutical research and development.

Spruce Biosciences, Inc.

Representative: John Paul Oleksiuk Cooley LLP, 1299 Pennsylvania Avenue, NW, Suite 700, Washington DC 20004, UNITED STATES OF AMERICA